Prevalence of sarcopenia in an Australian geriatric Medical Assessment Unit (MAU)

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12621000122853

Enrollment

Registered

2021-02-08

Start date

2021-02-23

Completion date

2021-08-19

Last updated

2023-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Research suggests sarcopenia effects approximately 6-22% of older adults worldwide. With an ageing population the prevalence and impact of sarcopenia are likely to increase, however it remains under-researched and under-diagnosed. A simple algorithm was developed by the European Working Group on Sarcopenia in Older People (EWGSOP) to assess for sarcopenia using validated outcome measures. This algorithm could be incorporated into the routine assessment of older adults admitted to hospital, and provide valuable information on the prevalence of this disorder. The aims of this study are (i) investigate the prevalence of sarcopenia in older adults admitted to an Australian geriatric Medical Assessment Unit (MAU) using the EWGSOP's algorithm, and (ii) examine the association between participants’ demographic and health characteristics, and sarcopenia-related outcomes (grip strength, muscle mass and gait speed)..

Interventions

Older adults admitted to an Australian geriatric Medical Assessment Unit (MAU) will be assessed for the presence of sarcopenia using the European Workings Group on Sarcopenia in Older People (EWGSOP) algorithm within 72 hours of admission to the MAU. This assessment will be completed once after consent is gained, there is no follow-up of participants. Sarcopenia is a progressive and generalised syndrome of skeletal muscles that involves accelerated loss of muscle function (defined by strength,

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Healthy volunteers

Inclusion criteria

- Aged 65 years or older - Admitted to the Prince of Wales Hospital geriatric MAU during the study period - Able to provide written consent, or has a suitable representative that can provide consent on their behalf (e.g. power of attorney, family member)

Exclusion criteria

- On end of life care pathway or terminally ill - Severe medical or psychology diagnosis that would prevent participation in the sarcopenia assessment.

Outcome results